Starpharma Holdings Limited (SPHRF)
OTCMKTS · Delayed Price · Currency is USD
0.0540
-0.0018 (-3.23%)
At close: Dec 18, 2024

Starpharma Holdings Income Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Jun '24 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2019 - 2015
Operating Revenue
9.769.764.214.92.156.56
Upgrade
Other Revenue
--0.140.261.340.56
Upgrade
Revenue
9.769.764.345.163.497.12
Upgrade
Revenue Growth (YoY)
124.64%124.64%-15.87%48.04%-50.99%161.58%
Upgrade
Cost of Revenue
10.6910.6912.3614.4615.8715.7
Upgrade
Gross Profit
-0.93-0.93-8.02-9.29-12.38-8.58
Upgrade
Selling, General & Admin
7.247.247.626.867.356.1
Upgrade
Operating Expenses
7.247.247.626.867.356.1
Upgrade
Operating Income
-8.17-8.17-15.64-16.15-19.73-14.68
Upgrade
Pretax Income
-8.17-8.17-15.64-16.15-19.73-14.68
Upgrade
Earnings From Continuing Operations
-8.17-8.17-15.64-16.15-19.73-14.68
Upgrade
Net Income
-8.17-8.17-15.64-16.15-19.73-14.68
Upgrade
Net Income to Common
-8.17-8.17-15.64-16.15-19.73-14.68
Upgrade
Shares Outstanding (Basic)
411411409407397372
Upgrade
Shares Outstanding (Diluted)
411411409407397372
Upgrade
Shares Change (YoY)
0.59%0.59%0.52%2.53%6.62%0.25%
Upgrade
EPS (Basic)
-0.02-0.02-0.04-0.04-0.05-0.04
Upgrade
EPS (Diluted)
-0.02-0.02-0.04-0.04-0.05-0.04
Upgrade
Free Cash Flow
-7.07-7.07-14.93-14-15.05-10.9
Upgrade
Free Cash Flow Per Share
-0.02-0.02-0.04-0.03-0.04-0.03
Upgrade
Gross Margin
-9.52%-9.52%-184.57%-180.05%--120.63%
Upgrade
Operating Margin
-83.69%-83.69%-360.07%-312.94%-565.87%-206.30%
Upgrade
Profit Margin
-83.69%-83.69%-360.07%-312.94%-565.87%-206.30%
Upgrade
Free Cash Flow Margin
-72.43%-72.43%-343.82%-271.19%-431.72%-153.21%
Upgrade
EBITDA
-7.85-7.85-15.25-15.8-19.43-14.4
Upgrade
EBITDA Margin
-80.45%-80.45%----202.43%
Upgrade
D&A For EBITDA
0.320.320.390.360.30.28
Upgrade
EBIT
-8.17-8.17-15.64-16.15-19.73-14.68
Upgrade
EBIT Margin
-83.69%-83.69%----206.30%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.